Eagle Pharmaceuticals
EGRX
#10470
Rank
NZ$5.45 M
Marketcap
NZ$0.41
Share price
0.00%
Change (1 day)
-80.31%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: NZ$5.45 Million

As of February 2026 Eagle Pharmaceuticals has a market cap of NZ$5.45 Million. This makes Eagle Pharmaceuticals the world's 10470th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$5.45 M-45.78%
2025NZ$10.06 M-20.33%
2024NZ$12.63 M-88.23%
2023NZ$0.10 B-82.08%
2022NZ$0.59 B-37.76%
2021NZ$0.96 B14.47%
2020NZ$0.84 B-30.83%
2019NZ$1.21 B45.49%
2018NZ$0.83 B-25.54%
2017NZ$1.12 B-36.68%
2016NZ$1.77 B-12.5%
2015NZ$2.02 B629.53%
2014NZ$0.27 B

End of Day market cap according to different sources

On Feb 7th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
NZ$5.45 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$959.53 B 17,577,843.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$501.78 B 9,192,213.24%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$1.574 T 28,838,477.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$343.76 B 6,297,377.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$209.42 B 3,836,368.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$200.56 B 3,674,141.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$66.21 B 1,212,840.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel